Lithium: the pharmacodynamic actions of the amazing ion
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
Lithium has been used for the treatment of mood disorders for over 60 years, yet the exact mechanisms by which it exerts its therapeutic effects remain unclear. Two enzymatic chains or pathways emerge as targets for lithium: inositol monophosphatase within the phosphatidylinositol signalling pathway and the protein kinase glycogen synthase kinase 3. Lithium inhibits these enzymes through displacing the normal cofactor magnesium, a vital regulator of numerous signalling pathways. Here we provide an overview of evidence, supporting a role for the inhibition of glycogen synthase kinase 3 and inositol monophosphatase in the pharmacodynamic actions of lithium. We also explore how inhibition of these enzymes by lithium can lead to downstream effects of clinical relevance, both for mood disorders and neurodegenerative diseases. Establishing a better understanding of lithium’s mechanisms of action may allow the development of more effective and more tolerable pharmacological agents for the treatment of a range of mental illnesses, and provide clearer insight into the pathophysiology of such disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in healthcare, many drugs for which the mechanism of action is unknown are trusted due to years of use that illustrate high efficacy and a clean safety profile (e.g., lithium14).”
From Machine intelligence in healthcare—perspectives on trustworthiness, explainability, usability, and transparency (2020) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 10×
“Although composed of two isoforms, GSK-3α and GSK-3β, which 166 http://tpp.sagepub.com generally have similar biochemical properties [Gould and Manji, 2005], much of the research in this area has focused on GSK-3β [Phiel and Klein, 2001].”
BackgroundInfluentialInositol phosphates and cell signalling
Berridge, M. J., & Irvine, R. F. (1989) · Nature · doi:10.1038/341197a0 · Cited by 4,058
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 6×
“Direct and indirect inhibition of GSK3 by lithium In 1996, two independent studies demonstrated lithium’s effects as a direct inhibitor of GSK3 in vitro and in cells [Klein and Melton, 1996; Stambolic et al. 1996].”
BackgroundInfluentialGSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · cited 2×
“2006] and is primarily regulated through inhibition of its activity via a combination of factors [Kaidanovick-Beilin and Woodgett, 2011], including phosphorylation, intracellular localisation and sequestration by binding proteins [Doble and Woodgett, 2003; Jope and Johnson, 2004; Kockeritz et al. 2006].”
BackgroundThe glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,517 · cited 2×
“2006] and is primarily regulated through inhibition of its activity via a combination of factors [Kaidanovick-Beilin and Woodgett, 2011], including phosphorylation, intracellular localisation and sequestration by binding proteins [Doble and Woodgett, 2003; Jope and Johnson, 2004; Kockeritz et al. 2006].”
BackgroundCohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478 · cited 2×
“…2010], and has a key role in the regulation of a number of cell functions, including insulin receptor signalling, the specification of cell fates during embryonic development, immunity and inflammation responses and neurotransmission [Cohen and Frame, 2001; KaidanovichBeilin and Woodgett, 2011].”
BackgroundLITHIUM SALTS IN THE TREATMENT OF PSYCHOTIC EXCITEMENT
Cade, J. F. J. (1949) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1949.tb36912.x · Cited by 1,463
Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J., & Su, B. (2006) · Cell · doi:10.1016/j.cell.2006.08.033 · Cited by 1,410 · cited 2×
“Activation of Akt involves phosphorylation of a regulatory threonine residue (Thr 308) by phosphatidylinositol-dependent kinase 1 (PDK1) and additional phosphorylation of the Ser 473 residue by the PDK2/TORC2 kinase [Alessi and Cohen, 1998; Jacinto et al. 2006], in response to phosphatidylinositol kinase (PI3K)-mediat…”
BackgroundMethodLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · cited 6×
“…lymphoma/leukaemia 2 (bcl-2) [Chen et al. 1999; Manji et al. 2000a; Moore et al. 2000b], as well as its effects on GSK3 [Klein and Melton, 1996; Stambolic et al. 1996; Chalecka-Franaszek and Chuang, 1999; De Sarno et al. 2002; Beaulieu et al. 2004], is thought to exert major neurotrophic…”
BackgroundInfluentialLithium salts in the treatment of psychotic excitement
Cade, J. F. J. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.1999.06241.x · Cited by 1,150
Research works printed but not linked: 1
- McQuade R., Robinson S. (2012) Attenuation of presynaptic dopamine function contributes to the effects of lithium on GSK-3β phosphorylation, in preparation. [Google Scholar]
Cited by
Items 101–146 of 146
Altered Protein Phosphorylation in a Novel Midbrain Organoid Model for Bipolar DisorderPreprint
Meyer, K., Woodworth, M., Gonçalves, M. C. B., Yue, M., Jandal, H. A., Morton, S., Lewandowski, M., Liu, N., Zigon, E. S., Fortuna, P. R. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.01.646642 · Cited by 2
“Notably, proteome and phosphoproteome analyses showed significant dysregulation of BD relevant signaling pathways including phosphatidylinositol (PI), glycogen synthase kinase-3 beta (GSK3B) and protein kinase B (AKT) signaling, validating the relevance of midbrain organoids for studying BD 29,34,35,41,57,58 .”
Effects of lithium chloride on queen egg‐laying performance and worker honey bee behavior
Sevin, S., Shimshoni, J. A., Afik, O., Shlomo, Z., & Shpigler, H. Y. (2025) · Pest Management Science · doi:10.1002/ps.70253 · Cited by 1
“28 It is plausible that a similar mechanism exists in honey bees, where Li in fl uences neural circuits governing aggression.”
Richard, S. A., Abem, V. K., & Roy, S. K. (2026) · Ibrain · doi:10.1002/ibra.70011 · Cited by 1
Lithium and the Brain–Bone Axis: A Bridge between Osteoporosis and Alzheimer’s Disease
Lee, J.-W., Hasegawa, T., Ikedo, A., Mizuno, K., Amizuka, N., & Kong, S. W. (2026) · Current Osteoporosis Reports · doi:10.1007/s11914-026-00954-5 · Cited by 3
“This mechanism likely operates in concert with inositol depletion via inhibition of inositol monophos-phatase [9], as well as other intracellular pathways [10 ].”
Lithium Toxicity in an Elderly Women within Normal Therapeutic Range : A Case Report
Mahmood, F. (2015) · Chattagram Maa-O-Shishu Hospital Medical College Journal · doi:10.3329/cmoshmcj.v14i2.25723 · Cited by 1
Modeling Complex Neurological Diseases with Stem Cells: A Study of Bipolar Disorder
Pernia, C. D., Nathan, N. H., Tobe, B. T. D., Winquist, A., Sidman, R. L., Goshima, Y., & Snyder, E. Y. (2018) · Results and problems in cell differentiation · doi:10.1007/978-3-319-93485-3_12 · Cited by 1
Azam, S., Bhattarai, N., Riveron, A., Rodriguez, S., Chapagain, P. P., & Mikšovská, J. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00399 · Cited by 1
Johnson, B. O., Oke, O. K., Nwabueze, C., Azam, M., & Ogunlesi, C. (2023) · Cureus · doi:10.7759/cureus.38370 · Cited by 1
“The mechanisms by which lithium exerts its therapeutic effects are still not fully understood [3,4].”
BackgroundIdentification of NEK3 and MOK as novel targets for lithium
Bravo, A., de Lucio, H., Sánchez‐Murcia, P. A., Jiménez-Ruíz, A., Petrone, P., Gago, F., & Cortés-Cabrera, Á. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13487 · Cited by 2
“It has been hypothesized that inhibition of GSK3β and inositol monophosphatase (Klein & Melton, 1996), together with other mechanisms such as alteration of glutamate receptors, could be responsible for the clinical effects of lithium ion (Brown & Tracy, 2012; Haimovich, Eliav, & Goldbourt, 2012).”
BackgroundPsychiatric Disorders and the RAS
D’Onofrio, S., Messias, E., & García‐Rill, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801385-4.00011-2
Lawford‐Smith, H. (2015)
Ketamine: The Glutamatergic Antidepressant and Its Efficacy
Tracy, D. K., Caddy, C., & Shergill, S. S. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_41
Self-citationRole of Serotonin2A (5-HT2A) Receptors in Epilepsy
Crunelli, V., Venzi, M., Deurwaerdère, P. D., & Giovanni, G. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_16 · Cited by 3
Deciphering the Systems Architecture of the Brain Using Molecular Can Openers
Nathan, N. H., Pernia, C. D., Tobe, B. T. D., Goshima, Y., Haggarty, S. J., Sidman, R. L., & Snyder, E. Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-812034-7.00017-0
Azam, S. (2019) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc008837
Frammenti di manoscritti ebraici medievali negli Archivi di Stato di Imola e Ravenna
Perani, M. (1991) · Bibliofilia: rivista di storia del libro e di bibliografia
Janicak, P. G., & Cutler, B. R. (2015) · Wiley eBooks · doi:10.1002/9781119951438.eibc2346
Fenn, G. D., Waller‐Evans, H., Atack, J. R., & Bax, B. D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.08.193284
Extrapyramidal Symptoms in a Bipolar 1 Patient Following Re-initiation of Lithium: A Case Report
Orji, G. I., Mansoor, M., Bellegarde, S. B., Punter, L., Odenigbo, N., & Fouron, P. (2023) · Cureus · doi:10.7759/cureus.39361
“Lithium is said to inhibit two enzymatic pathways: inositol monophosphatase within the phosphatidylinositol signaling pathway, and the protein kinase glycogen synthase kinase [1,3,5].”
BackgroundHamirani, F., Samarbafzadeh, E., & Kablinger, A. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00012-9
Jon litu – niezwykły środek psychotropowy
RYBAKOWSKI, J. K. (2022) · Nauka · doi:10.24425/nauka.2022.140344 · Cited by 1
Lyons, C., & Gossell‐Williams, M. (2024) · Caribbean Medical Journal · doi:10.48107/cmj.2024.03.001
Farhangdoost, N., Pietrantonio, A., Liu, Y., Liao, C., Rochefort, D. L., Pacis, A., Alda, M., Dion, P. A., Chaumette, B., Khayachi, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.24.639480
Wesley, M. S., Munivenkatappa, M., & Thirthalli, J. (2025) · Indian Journal of Psychological Medicine · doi:10.1177/02537176251323887
“15 Similarly, side effects of medication were also an important contributor to their distress.”
Lithium-Induced Hyperparathyroidism (LHPT)
Meehan, A. D., & Wallin, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-81813-4_38 · Cited by 1
Pharmacological Roles of Lithium in Treatment of Diseases: New Insights
Ghamry, M. E., Ibrahim, I. A. A. E.-H., Elshazly, S. M., & Fahmy, A. (2025) · World s Veterinary Journal · doi:10.54203/scil.2025.wvj53
Alla, I. R., & Chung, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.13.670149
Cold and lithium delay forgetting of olfactory memories in Caenorhabditis elegans
Landschaft-Berliner, D., Goldstein, K., Teichman, G., Anava, S., Gingold, H., Salzberg, Y., Rieger, I., Levy, N., Pechuk, V., Setty, H., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02143-6 · Cited by 6
“Still, it is well established that lithium inhibits various phosphoinositol phosphates that function in inositol phosphate metabolism, such as IMPase and inositol polyphosphatase 1-phosphatase, which influence DAG turnover 48,49 .”
Sun, J., Yang, X., Jiang, W., Ji, C., Wu, Y., Sun, H., Liu, X., Yamamoto, M., Tsukamoto, T., Nomura, S., et al. (2026) · Advanced Science · doi:10.1002/advs.202521746
Yates, J. R. (2026) · Springer eBooks · doi:10.1007/978-3-032-15602-0_9
Small‐Molecule Kinase Inhibitors Modulating Circadian Rhythms
Castellino, I., Bartolini, M., Andrýs, R., & Musílek, K. (2026) · Medicinal Research Reviews · doi:10.1002/med.70071
“Such discrepancies may be attributed to the lack of selectivity of lithium [86, 87], which may also affect other pathways that influence circadian rhythms [88, 89].”
Rijavec, N., & Večerić‐Haler, Ž. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156730
“Through interference with these magnesium-dependent enzymatic processes, lithium influences down-stream signaling networks involved in synaptic plasticity, neurotrophic signaling, neuronal survival, apoptosis, stress-response regulation, and circadian biology [6].”
Behavioral and redox effects of lithium and curcumin in a planarian model of sublethal stress
de Lima, R. H., Souza-Aguiar, V. E., & Braguini, W. L. (2026) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2026.105135
Manifestations of Lithium Deficiency in the Human Body: What is Known to Date (A Narrative Review)
Cherpakov, R. A., Grebenchikov, O. A., Makarova, A. M., Antonova, V. V., & Boeva, E. A. (2026) · Biological Trace Element Research · doi:10.1007/s12011-026-05325-w · Cited by 1
Luan, X., Fan, B., Wang, X., Li, X., Song, Y., Zhang, X., Zhang, H., Chen, R., Li, Y., Yang, Z., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1915614
“Competes with Mg2+ at GSK-3 and also regulates upstream pathways; it is not isoform-selective (32).”
Гоглов, И. (2026) · Journal of Bioinformatics and Genomics · doi:10.60797/jbg.2026.33.6
Exact gene overlap between the strict BD mapping set and quantitative Tier 1 targets
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.4
Pathway enrichment across BD mapping and drug-evidence layers
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.5
Ranked candidate evidence assessment
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.3
Drug classes and representative molecular target categories included in the analysis
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.2
Key genomic studies of bipolar disorder
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.1
Primary g:Profiler enrichment by evidence layer
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.6
Cross-layer evidence and calcium sensitivity analysis
Гоглов, И. (2026) · Cifra LLC Journals · doi:10.60797/jbg.2026.33.6.7
Lithium in Kleine-Levin syndrome: a systematic review of case-based and observational evidence
Silva, M. V. Q., da Silva, T. D. C. E. S., Cândido, A. S., & Fontana, A. P. (2026) · Journal of Rare Diseases · doi:10.1007/s44162-026-00249-4
“Lithium modulates targets such as inositol monophosphatase (IMPase) and glycogen synthase kinase-3β (GSK-3β) —pathways involved in neuronal homeostasis and the regulation of circadian rhythms [13, 44, 45].”
BindingDB (2020) · UC San Diego · doi:10.7270/q2w37zwm
Metadata
- Authors
- Brown, K. M., & Tracy, D. K.
- Affiliations
- King's College London (GB)
- Oxleas NHS Foundation Trust (GB)
- ORCID
- Tracy, Derek K.
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2012-12-21
- Volume
- 3
- Issue
- 3
- Pages
- 163-176
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- PMC
- PMC3805456
- OpenAlex
- W2131991500
- Cited by
- 140
- References
- 124
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 9 · 2019: 10 · 2018: 10 · 2017: 9 · 2016: 9 · 2015: 18 · 2014: 8 · 2013: 1
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Psychopharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- lithium, pharmacodynamics, glycogen synthase kinase-3, inositol monophosphatase, magnesium cofactor, mood disorders, neurodegenerative diseases, enzyme inhibition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.